Page last updated: 2024-10-30

maprotiline and Exanthem

maprotiline has been researched along with Exanthem in 1 studies

Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.

Research Excerpts

ExcerptRelevanceReference
" The first 2 days patients received a high initial dosage of 300 mg per day."2.64[Clinical double-blind study with two different dosages of maprotiline (150 and 225 mg per day) (author's transl)]. ( Angst, J; Gmuer, M; Hess, K; Hurwitz, E; Martens, H; Rothweiler, R; Steiner, A; Woggon, B, 1976)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Woggon, B1
Angst, J1
Gmuer, M1
Hess, K1
Hurwitz, E1
Martens, H1
Rothweiler, R1
Steiner, A1

Trials

1 trial available for maprotiline and Exanthem

ArticleYear
[Clinical double-blind study with two different dosages of maprotiline (150 and 225 mg per day) (author's transl)].
    Archiv fur Psychiatrie und Nervenkrankheiten, 1976, Sep-17, Volume: 222, Issue:1

    Topics: Adult; Anthracenes; Clinical Trials as Topic; Depression; Dose-Response Relationship, Drug; Exanthem

1976